Nuance Communications announced that Leidos, a Fortune 500® science and technology leader, will use Nuance's AI technology as part of their scalable and customisable digital patient engagement solutions for health systems and federal healthcare agencies.
Using the Nuance Mix™ conversational AI development platform, Leidos will help customers accelerate IT modernisation, enhance patient experiences, and improve care costs and outcomes.
Nuance Mix is an enterprise-grade cloud-based conversational AI development platform that extends the capabilities of Nuance's Patient Engagement portfolio of solutions. It enables organisations to rapidly develop, test, deploy, and optimise virtual assistant, natural language, and speech solutions, reducing development and optimisation time by more than 50 percent.
Liz Porter, Leidos Health Group president, said: "Our collaboration with Nuance adds important tools and flexibility to help build solutions that advance our customers' missions to improve care quality, costs, and outcomes. The Nuance conversational AI platform and support team gives us the power to deploy enterprise-grade conversational AI and intelligent omnichannel development tools to design and deliver advanced, customized digital patient engagement solutions."
Diana Nole, Executive Vice President and General Manager of Healthcare at Nuance, said:
"Healthcare providers are rapidly embracing modern omnichannel conversational AI technologies that improve experiences for patients and clinicians alike."
"With decades of experience modernizing enterprise IT infrastructures and solving difficult challenges, Leidos in collaboration with Nuance is poised to be a leader in helping healthcare organizations open their digital front doors with scalable patient engagement virtual assistant solutions."